tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Aldeyra Therapeutics (ALDX), Equillium (EQ) and Stealth Biotherapeutics (MITO)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Aldeyra Therapeutics (ALDXResearch Report), Equillium (EQResearch Report) and Stealth Biotherapeutics (MITOResearch Report) with bullish sentiments.

Aldeyra Therapeutics (ALDX)

Berenberg Bank analyst Esther Hong maintained a Buy rating on Aldeyra Therapeutics today and set a price target of $28.00. The company’s shares closed last Friday at $2.85, close to its 52-week low of $2.36.

According to TipRanks.com, Hong has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -24.6% and a 24.7% success rate. Hong covers the Healthcare sector, focusing on stocks such as Cerevel Therapeutics Holdings, ACADIA Pharmaceuticals, and Axsome Therapeutics.

Aldeyra Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $20.83.

See today’s best-performing stocks on TipRanks >>

Equillium (EQ)

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Equillium, with a price target of $15.00. The company’s shares closed last Friday at $2.50, close to its 52-week low of $2.12.

According to TipRanks.com, Selvaraju is ranked 0 out of 5 stars with an average return of -45.1% and a 9.6% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Santhera Pharmaceuticals Holding AG, Inovio Pharmaceuticals, and Aquestive Therapeutics.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Equillium with a $14.50 average price target, representing a 462.0% upside. In a report issued on May 13, Stifel Nicolaus also reiterated a Buy rating on the stock.

Stealth Biotherapeutics (MITO)

In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Stealth Biotherapeutics, with a price target of $1.50. The company’s shares closed last Friday at $0.24, close to its 52-week low of $0.17.

According to TipRanks.com, Chen has 0 stars on 0-5 stars ranking scale with an average return of -9.3% and a 33.2% success rate. Chen covers the Healthcare sector, focusing on stocks such as Ortho Clinical Diagnostics Holdings, Interpace Diagnostics Group, and HTG Molecular Diagnostics.

Stealth Biotherapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $1.25.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ALDX:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
---

Latest News Feed